Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy.

Becker PM, Schwartz JR, Feldman NT, Hughes RJ.

Department of Psychiatry,
University of Texas Southwestern Medical Center
 Dallas, Texas, USA
 pbecker@sleepmed.com
Psychopharmacology (Berl). 2004 Jan; 171(2): 133-9.

Abstract

INTRODUCTION. In addition to excessive sleepiness, patients with narcolepsy often have significant fatigue, depressed mood, and decreased quality of life. OBJECTIVE. To determine whether treatment with modafinil for excessive sleepiness improves fatigue, mood, and health-related quality of life (HRQOL) in patients with narcolepsy.

MATERIALS AND METHODS. Outpatients with narcolepsy underwent a 14-day washout of psychostimulants and then were enrolled in this 6-week, open-label, multicenter study. Patients received modafinil starting at 200 mg once daily for week 1, and then 200 or 400 mg daily for weeks 2 through 6. Efficacy was evaluated using the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) and the Profile of Mood States (POMS). Safety was assessed by monitoring adverse events (AE).

RESULTS. At baseline, 151 patients had moderate to severe excessive sleepiness (mean Epworth Sleepiness Scale score=17.8+/-4.4). Most patients (>/=70% of 123 who completed the study) received 400 mg modafinil once daily during weeks 2 through 6. Modafinil significantly improved HRQOL, based on SF-36 measures of mental and physical component summary scores and subdomain scores of role-physical, social functioning, and vitality (each P<0.001). Modafinil treatment was also associated with significantly reduced fatigue and significantly improved vigor and cognition as assessed by the POMS (each P<0.001) from weeks 1 through 6. The most frequent AE with modafinil treatment were headache, nausea, and insomnia; most AE were mild or moderate in nature. Only seven patients (5%) withdrew from the study because of AE.

CONCLUSION. In narcolepsy patients who were switched from psychostimulants, modafinil therapy improved health-related quality of life and subjective feelings of vigor and cognitive functioning and reduced fatigue.



 1.   Modafinil  for sustaining the alertness of helicopter pilots
 2.   Modafinil  augmentation of antidepressant treatment
 3.   Modafinil  the unique properties of a new stimulant 
 4.   Modafinil  children with attention-deficit/hyperactivity disorder
 5.   Modafinil  dosage and safety
 6.   Modafinil  successful treatment of hypersomnia & narcolepsy
 7.   Modafinil  narcolepsy: symptoms and management
 8.   Modafinil  amplification of cortical serotonin release
 9.   Modafinil  treatment of alcoholic organic brain syndrome
10.  Modafinil  effect on melatonin, cortisol, and growth hormone
11.  Modafinil  in obstructive sleep apnea-hypopnea syndrome
12.  Modafinil  vs dextroamphetamine in treatment of adult ADHD
13.  Modafinil  efficacy in narcolepsy
14.  Modafinil  switching from narcolepsy drugs to modafinil
15.  Modafinil  dopaminergic transmission mediates CNS stimulants

| Home | Order |
 

 





Hit Counter